The Journal of Experimental Medicine
Torrey Pines Biolabs
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article
Right arrow Full Text
Right arrow Full Text (PDF, 634K)
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yang, T.-Y.
Right arrow Articles by Lira, S. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yang, T.-Y.
Right arrow Articles by Lira, S. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
© The Rockefeller University Press, 0022-1007/2000/2/445/ $5.00
The Journal of Experimental Medicine, Volume 191, Number 3, February 7, 2000 445-454


Original Article

Transgenic Expression of the Chemokine Receptor Encoded by Human Herpesvirus 8 Induces an Angioproliferative Disease Resembling Kaposi's Sarcoma

Tong-Yuan Yanga, Shu-Cheng Chena, Michael W. Leachb, Denise Manfraa, Bernhard Homeyc, Maria Wiekowskia, Lee Sullivana, Chung-Her Jenha, Satwant K. Narulaa, Stephen W. Chensued, and Sergio A. Liraa
a From the Department of Immunology, Schering-Plough Research Institute, Kenilworth, New Jersey 07033
b From the Department of Drug Safety and Metabolism, Schering-Plough Research Institute, Kenilworth, New Jersey 07033
c Department of Immunology, DNAX Research Institute, Palo Alto, California 94304
d Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan 48109

Correspondence to: Sergio A. Lira, Dept. of Immunology, Schering-Plough Research Institute, 2015 Galloping Hill Rd., Kenilworth, NJ 07033. Tel:908-740-3088 Fax:908-740-3084 E-mail:sergio.lira{at}spcorp.com.

Human herpesvirus 8 (HHV8, also known as Kaposi's sarcoma [KS]-associated herpesvirus) has been implicated as an etiologic agent for KS, an angiogenic tumor composed of endothelial, inflammatory, and spindle cells. Here, we report that transgenic mice expressing the HHV8-encoded chemokine receptor (viral G protein–coupled receptor) within hematopoietic cells develop angioproliferative lesions in multiple organs that morphologically resemble KS lesions. These lesions are characterized by a spectrum of changes ranging from erythematous maculae to vascular tumors, by the presence of spindle and inflammatory cells, and by expression of vGPCR, CD34, and vascular endothelial growth factor. We conclude that vGPCR contributes to the development of the angioproliferative lesions observed in these mice and suggest that this chemokine receptor may play a role in the pathogenesis of KS in humans.

Key Words: ORF74, viral pathogenesis, animal model, angiogenesis, VEGF


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS